EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells.
CD27
EGFR
T cell
bispecific antibody
co-stimulation
immunotherapy
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
22
03
2023
accepted:
03
07
2023
medline:
8
8
2023
pubmed:
7
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
A higher density of tumor infiltrating lymphocytes (TILs) in the tumor microenvironment, particularly cytotoxic CD8
Identifiants
pubmed: 37545491
doi: 10.3389/fimmu.2023.1191866
pmc: PMC10399592
doi:
Substances chimiques
ErbB Receptors
EC 2.7.10.1
Antibodies, Bispecific
0
EGFR protein, human
EC 2.7.10.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1191866Informations de copyright
Copyright © 2023 Melo, Nelemans, Vlaming, Lourens, Wiersma, Bilemjian, Huls, de Bruyn and Bremer.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Exp Med. 2017 Feb;214(2):381-400
pubmed: 28115575
Cancer Immunol Immunother. 2020 Oct;69(10):2125-2137
pubmed: 32451681
Cell. 2016 Feb 11;164(4):780-91
pubmed: 26830878
Nat Biotechnol. 2020 Jun;38(6):675-678
pubmed: 32444850
Front Oncol. 2020 Jul 24;10:1249
pubmed: 32793499
J Immunother Cancer. 2015 Aug 18;3:37
pubmed: 26500773
Arch Biochem Biophys. 1987 Feb 1;252(2):549-60
pubmed: 2434025
Protein Eng Des Sel. 2016 Oct;29(10):457-466
pubmed: 27578889
Immunity. 2016 May 17;44(5):973-88
pubmed: 27192564
Commun Biol. 2022 Mar 14;5(1):229
pubmed: 35288635
J Immunol. 2009 Aug 1;183(3):1851-61
pubmed: 19596991
Front Cell Dev Biol. 2022 May 30;10:908389
pubmed: 35712656
Immunol Rev. 2009 May;229(1):126-44
pubmed: 19426219
J Immunol. 2013 Sep 15;191(6):3025-36
pubmed: 23940275
Eur J Cancer. 2001 Sep;37 Suppl 4:S9-15
pubmed: 11597399
J Immunol. 1991 Nov 1;147(9):3165-9
pubmed: 1655907
J Exp Med. 2013 Apr 8;210(4):715-28
pubmed: 23547099
Cancer Biol Ther. 2010 Nov 15;10(10):983-93
pubmed: 20855968
J Immunol. 2013 Aug 15;191(4):1976-83
pubmed: 23842750
Oncoimmunology. 2018 May 31;7(8):e1466016
pubmed: 30221065
Genes Cancer. 2017 May;8(5-6):589-599
pubmed: 28740577
Oncoimmunology. 2020 Sep 29;9(1):1824323
pubmed: 33299654
Am J Clin Dermatol. 2019 Feb;20(1):41-54
pubmed: 30259383
J Clin Invest. 2010 Jan;120(1):168-78
pubmed: 19955658
Cochrane Database Syst Rev. 2018 Oct 16;10:CD007927
pubmed: 30321910
Eur J Immunol. 1997 Jan;27(1):239-47
pubmed: 9022025
Front Oncol. 2015 Jun 08;5:117
pubmed: 26106583
Clin Cancer Res. 2016 Feb 1;22(3):714-24
pubmed: 26384738
Clin Cancer Res. 2012 Jul 15;18(14):3812-21
pubmed: 22589397
Clin Cancer Res. 2017 Apr 15;23(8):1929-1936
pubmed: 27756788
Lab Invest. 2011 Apr;91(4):598-608
pubmed: 21321535
Int J Mol Sci. 2022 Feb 23;23(5):
pubmed: 35269611
Oncotarget. 2016 Nov 15;7(46):75130-75144
pubmed: 27650547
Commun Biol. 2020 Jul 14;3(1):375
pubmed: 32665635
J Immunother. 2010 Oct;33(8):769-79
pubmed: 20842060
Cancer Discov. 2018 Sep;8(9):1069-1086
pubmed: 30115704
ISRN Oncol. 2013 Jun 11;2013:371854
pubmed: 23840967
J Immunol. 2011 Aug 15;187(4):1754-63
pubmed: 21742972
Int J Mol Sci. 2022 Jun 10;23(12):
pubmed: 35742933
Ther Adv Med Oncol. 2018 Dec 17;10:1758835918816281
pubmed: 30574212
Front Immunol. 2017 Dec 04;8:1597
pubmed: 29255458
J Mol Med (Berl). 2022 Mar;100(3):439-449
pubmed: 34423375
J Biol Chem. 2005 Mar 18;280(11):10025-33
pubmed: 15644326
Breast Cancer Res Treat. 2009 Jul;116(1):69-77
pubmed: 18592372
Blood Adv. 2020 May 12;4(9):1917-1926
pubmed: 32380537
J Immunother Cancer. 2022 Sep;10(9):
pubmed: 36100308
ESMO Open. 2020 Mar;4(Suppl 3):e000629
pubmed: 32152062
Front Immunol. 2021 Aug 16;12:719116
pubmed: 34484225
Immunity. 2018 Apr 17;48(4):812-830.e14
pubmed: 29628290
J Clin Oncol. 2017 Jun 20;35(18):2028-2036
pubmed: 28463630
Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19501-6
pubmed: 24218606
Sci Rep. 2020 Mar 13;10(1):4662
pubmed: 32170146
J Immunol. 2011 Nov 1;187(9):4421-5
pubmed: 21949017
Curr Opin Immunol. 2005 Jun;17(3):275-81
pubmed: 15886117
Clin Cancer Res. 2018 May 15;24(10):2383-2394
pubmed: 29514845
Nat Rev Cancer. 2020 Apr;20(4):218-232
pubmed: 32024970
FEBS J. 2016 Sep;283(18):3325-34
pubmed: 27191544
Sci Transl Med. 2020 Jun 24;12(549):
pubmed: 32581132
Gut. 2017 Feb;66(2):342-351
pubmed: 26669617
Genome Res. 2021 Oct;31(10):1913-1926
pubmed: 34548323
Hepatology. 2019 Nov;70(5):1804-1815
pubmed: 31077406
Sci Adv. 2022 Dec 16;8(50):eabn7983
pubmed: 36525493
Blood. 2007 Oct 1;110(7):2537-44
pubmed: 17615291
J Nucl Med. 2017 Oct;58(10):1560-1566
pubmed: 28522738
MAbs. 2013 May-Jun;5(3):364-72
pubmed: 23572180
Appl Microbiol Biotechnol. 1996 Dec;46(5-6):524-32
pubmed: 9008885
J Immunol. 2013 Oct 15;191(8):4174-83
pubmed: 24026078
Cancer Treat Rev. 2018 Feb;63:122-134
pubmed: 29287242
Genome Biol. 2015 Dec 10;16:278
pubmed: 26653891
Nat Immunol. 2002 Jan;3(1):83-90
pubmed: 11743585
J Exp Clin Cancer Res. 2019 Jun 13;38(1):255
pubmed: 31196207
Adv Exp Med Biol. 2018;1110:113-131
pubmed: 30623369
Nat Immunol. 2000 Nov;1(5):433-40
pubmed: 11062504
Cancer Res. 2012 Jul 15;72(14):3664-76
pubmed: 22628427
Science. 2015 Apr 3;348(6230):56-61
pubmed: 25838373
Science. 1996 Mar 22;271(5256):1734-6
pubmed: 8596936
J Immunol. 2008 Jul 15;181(2):1071-82
pubmed: 18606659
Gynecol Oncol Res Pract. 2016 Nov 24;3:11
pubmed: 27904752